Combat Drugs reports standalone net loss of Rs 0.08 crore in the June 2017 quarter
Sales rise 33.33% to Rs 0.04 crore
Net Loss of Combat Drugs reported to Rs 0.08 crore in the quarter ended June 2017 as against net loss of Rs 0.08 crore during the previous quarter ended June 2016. Sales rose 33.33% to Rs 0.04 crore in the quarter ended June 2017 as against Rs 0.03 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales0.040.03 33 OPM %-200.00-266.67 -PBDT-0.08-0.08 0 PBT-0.08-0.08 0 NP-0.08-0.08 0Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 12 2017 | 4:31 PM IST